TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15340092

Group type: EXPERIMENTAL
Intervention: Polysulphone membrane during haemodialysis
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Polyamide membrane during haemodialysis
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Polysulphone membrane perfused with blood without dialysate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Polyamide membrane perfused with blood without dialysate
Number of subjects: 24
Study: 11489714

Group type: EXPERIMENTAL
Intervention: Intraurethral prostaglandin E(1) (MUSE)
Number of subjects: 72
Study: 9880199

Group type: EXPERIMENTAL
Intervention: ST elevation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ST depression
Number of subjects: 0

Group type: COMPARATOR
Intervention: No ST changes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ST segment depression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ST segment elevation
Number of subjects: 0

Group type: COMPARATOR
Intervention: No ST deviation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ST segment depression vs ST elevation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ST elevation with concomitant ST depression
Number of subjects: 0

Group type: COMPARATOR
Intervention: ST elevation without concomitant ST depression
Number of subjects: 0
Study: 7572617

Group type: EXPERIMENTAL
Intervention: High-intensity exercise training (85% of maximal oxygen consumption)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Low-intensity exercise training (50% of maximal oxygen consumption)
Number of subjects: 200
Study: 2205962

Group type: EXPERIMENTAL
Intervention: Early occupational therapy (1-3 days after injury)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual treatment
Number of subjects: 40
Study: 6107722

Group type: EXPERIMENTAL
Intervention: Intra-articular injection of acetylsalicylic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrocortisone acetate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 0
Study: 31888745

Group type: EXPERIMENTAL
Intervention: CT MEWS/SBAR guide
Number of subjects: 292

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 292
Study: 28478041

Group type: COMPARATOR
Intervention: Brief intervention (n=211)
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: 12-week weight-management programme (n=528)
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: 52-week weight-management programme (n=528)
Number of subjects: 1267
Study: 24975199

Group type: EXPERIMENTAL
Intervention: AFL-dPDT
Number of subjects: 16

Group type: COMPARATOR
Intervention: dPDT
Number of subjects: 16

Group type: COMPARATOR
Intervention: cPDT
Number of subjects: 16

Group type: COMPARATOR
Intervention: AFL
Number of subjects: 16
Study: 23958271

Group type: EXPERIMENTAL
Intervention: prednisolone
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: pentoxifylline
Number of subjects: 1200

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1200
Study: 21163311

Group type: EXPERIMENTAL
Intervention: Positively framed attitude intervention
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Negatively framed attitude intervention
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Perceived Behavioural Control (PBC) intervention
Number of subjects: 349

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 349
Study: 18482867

Group type: EXPERIMENTAL
Intervention: Valerian (300 mg nightly for 2 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (nightly for 2 weeks)
Number of subjects: 16
Study: 17118503

Group type: EXPERIMENTAL
Intervention: Rubber hand placed at varying distances (17.5‐67.5cm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Time taken to elicit the illusion
Number of subjects: 0
Study: 15090577

Group type: EXPERIMENTAL
Intervention: Short term video EEG (SVEEG) recordings
Number of subjects: 143
Study: 11332873

Group type: EXPERIMENTAL
Intervention: Amoxicilina 250 mg/5 ml oral suspension
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Amoxicilina 500 mg capsule
Number of subjects: 48

Group type: COMPARATOR
Intervention: Amoxil 250 mg/5 ml oral suspension
Number of subjects: 48

Group type: COMPARATOR
Intervention: Amoxil capsule 500 mg
Number of subjects: 48
Study: 9440359

Group type: EXPERIMENTAL
Intervention: Induction segment centered at the tip of the test segment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lateral displacement of induction segment from the tip of the test segment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pair of induction segments on each side of the tip of the test segment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fixed position and orientation of an induction segment
Number of subjects: 0
Study: 7816289

Group type: EXPERIMENTAL
Intervention: ANF (0.83 microgram/min)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 3404378

Group type: COMPARATOR
Intervention: Continuous intravenous oxytocin infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pulsatile intravenous oxytocin infusion (every 8 minutes)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pulsatile intravenous oxytocin infusion
Number of subjects: 20
Study: 28102098

Group type: EXPERIMENTAL
Intervention: Juice PLUS+ (JP) for 12 weeks, n = 72
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo for 12 weeks, n = 62
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Juice PLUS+ (JP) use following the initial 12-week trial
Number of subjects: 134
Study: 28108777

Group type: EXPERIMENTAL
Intervention: Autologous Matrix‐Induced Chondrogenesis (AMIC®)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Microfracture (MFx)
Number of subjects: 47
Study: 26637812

Group type: EXPERIMENTAL
Intervention: RBC units stored 25 to 35 days (longer-storage group; n=145)
Number of subjects: 290

Group type: COMPARATOR
Intervention: RBC units stored 1 to 10 days (shorter-storage group; n=145)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 290
Study: 23545926

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid with lidocaine (HA+L)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Both HA and HA+L
Number of subjects: 119
Study: 20887146

Group type: EXPERIMENTAL
Intervention: OP‐1 Putty
Number of subjects: 336

Group type: COMPARATOR
Intervention: Autogenous iliac crest bone graft
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 336
Study: 18373141

Group type: EXPERIMENTAL
Intervention: Computerized decision support (CDS) for 18 months
Number of subjects: 2027

Group type: COMPARATOR
Intervention: Usual care without computerized support
Number of subjects: 2027
Study: 16637317

Group type: EXPERIMENTAL
Intervention: Diagnostic flexible hysteroscopy
Number of subjects: 569

Group type: COMPARATOR
Intervention: Classical endometrial curettage
Number of subjects: 569
Study: 12731685

Group type: EXPERIMENTAL
Intervention: 12 months of case management delivered by paraprofessionals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brief contact condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amount of case management received
Number of subjects: 0
Study: 10980887

Group type: EXPERIMENTAL
Intervention: Permanent dual-chamber pacing
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo effect from pacemaker implantation
Number of subjects: 140
Study: 8764799

Group type: EXPERIMENTAL
Intervention: 50 micrograms/ml latanoprost once daily
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 15 micrograms/ml latanoprost twice daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 1530677

Group type: COMPARATOR
Intervention: Placebo (PCB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amezinium (AMZ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (DHE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Midodrine (MDD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxilofrine (OXF)
Number of subjects: 0
Study: 3968001

Group type: EXPERIMENTAL
Intervention: 4 h thermal dehydration followed by 2 h head‐out water immersion
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 4 h thermal dehydration followed by 2 h chair rest
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 4 h thermal dehydration
Number of subjects: 9

Group type: COMPARATOR
Intervention: 6 h of rest in the supine position
Number of subjects: 9
Study: 30796036

Group type: EXPERIMENTAL
Intervention: Trastuzumab treatment
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Trastuzumab treatment (after exclusion of lowest HER2 expressers)
Number of subjects: 180
Study: 29990661

Group type: EXPERIMENTAL
Intervention: Full-CAT (n=52)
Number of subjects: 95

Group type: COMPARATOR
Intervention: CAT minus narrative reformulation (CAT-NR, n=43)
Number of subjects: 95
Study: 26435365

Group type: EXPERIMENTAL
Intervention: Insulin degludec/insulin aspart
Number of subjects: 394

Group type: COMPARATOR
Intervention: Biphasic insulin aspart 30
Number of subjects: 394
Study: 25007693

Group type: EXPERIMENTAL
Intervention: Intravenous morphine 100 microgram/kg before skin incision
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ilioinguinal/iliohypogastric nerve block with 0.25 ml/kg bupivacaine 0.5% before skin incision
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ilioinguinal/iliohypogastric nerve block
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Intravenous morphine
Number of subjects: 70
Study: 23158942

Group type: EXPERIMENTAL
Intervention: Chinese medicine for promoting blood circulation and removing blood stasis
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 19283561

Group type: EXPERIMENTAL
Intervention: Very low dose naltrexone (VLNTX) 0.125 or 0.250 mg per day
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Very low dose naltrexone (VLNTX)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 17224720

Group type: EXPERIMENTAL
Intervention: Tiagabine (4 mg/d initiated, titrated to a maximum of 16 mg/d)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Tiagabine
Number of subjects: 232

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 232
Study: 15031340

Group type: EXPERIMENTAL
Intervention: Urokinase (UK) + Benazepril (BZ)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Benazepril (BZ) alone
Number of subjects: 71
Study: 11772224

Group type: EXPERIMENTAL
Intervention: Partial splenic autotransplantation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (splenectomy)
Number of subjects: 20
Study: 9839657

Group type: EXPERIMENTAL
Intervention: Transfer Factor (TF)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Acyclovir
Number of subjects: 28
Study: 8205601

Group type: EXPERIMENTAL
Intervention: Synergized natural pyrethrins mousse (single application, 10-minute duration)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Permethrin creme rinse (control)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Synergized natural pyrethrins mousse
Number of subjects: 52
Study: 2723116

Group type: EXPERIMENTAL
Intervention: HP 029 (5 to 200 mg)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 29405944

Group type: EXPERIMENTAL
Intervention: High-intensity treadmill exercise for 15 minutes
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (sat for 15 minutes)
Number of subjects: 44
Study: 27322814

Group type: EXPERIMENTAL
Intervention: Bosentan (ET receptor antagonist)
Number of subjects: 36

Group type: COMPARATOR
Intervention: ET-1 stimulation
Number of subjects: 36
Study: 25233646

Group type: EXPERIMENTAL
Intervention: Floating-needle therapy combined with rehabilitation training
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional acupuncture combined with rehabilitation training
Number of subjects: 100
Study: 24211338

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Light therapy (LT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) + Light therapy (CBT + LT)
Number of subjects: 0
Study: 20444568

Group type: EXPERIMENTAL
Intervention: Trained clinicians
Number of subjects: 403

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 403
Study: 18349800

Group type: EXPERIMENTAL
Intervention: (90)Y‐DOTA‐D‐Phe(1)‐Tyr(3)‐octreotide
Number of subjects: 6

Group type: COMPARATOR
Intervention: (111)In‐DTPA‐D‐Phe(1)‐octreotide
Number of subjects: 6
Study: 17033231

Group type: EXPERIMENTAL
Intervention: UFT+TAM therapy
Number of subjects: 164

Group type: COMPARATOR
Intervention: CAF therapy
Number of subjects: 164
Study: 12689404

Group type: EXPERIMENTAL
Intervention: Transurethral needle ablation (TUNA)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 59
Study: 10735896

Group type: EXPERIMENTAL
Intervention: Temozolomide (TMZ)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Procarbazine (PCB)
Number of subjects: 288
Study: 9366769

Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 5% dextrose in lactated Ringer's solution (D5RL)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 5% dextrose in water (D5W)
Number of subjects: 24
Study: 1412183

Group type: EXPERIMENTAL
Intervention: Warfarin, INR = 2.5 - 4.2 (n = 34)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA), 300 mg/d (n = 30)
Number of subjects: 64
Study: 3997967

Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 30897198

Group type: EXPERIMENTAL
Intervention: bIgG against CS17
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: bIgG against CsbD
Number of subjects: 36
Study: 30530821

Group type: EXPERIMENTAL
Intervention: Brief behavioural intervention
Number of subjects: 272

Group type: COMPARATOR
Intervention: Leaflet on healthy living (comparator)
Number of subjects: 272
Study: 26659245

Group type: EXPERIMENTAL
Intervention: Ultrasonic scissors dissection (fundus-first approach)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Diathermy hook dissection (starting from the triangle of Calot)
Number of subjects: 169
Study: 25080537

Group type: EXPERIMENTAL
Intervention: Healthy Nordic diet (ND)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 166
Study: 22553047

Group type: EXPERIMENTAL
Intervention: Advertising image used in the health communication campaign 'Mummy Drinks Baby Drinks'
Number of subjects: 690
Study: 19357113

Group type: EXPERIMENTAL
Intervention: Pamapimod (up to 300 mg once daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pamapimod
Number of subjects: 0
Study: 18519297

Group type: EXPERIMENTAL
Intervention: Intervention group (n=237)
Number of subjects: 457

Group type: COMPARATOR
Intervention: Control group (n=220)
Number of subjects: 457
Study: 17022846

Group type: EXPERIMENTAL
Intervention: Rapidly absorbed paracetamol tablet (PS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard paracetamol tablet (P)
Number of subjects: 30
Study: 14581655

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 5 mg nasal spray
Number of subjects: 816

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 816
Study: 10887232

Group type: EXPERIMENTAL
Intervention: Autologous blood clot (ABCS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No autologous blood clot
Number of subjects: 100
Study: 7490815

Group type: EXPERIMENTAL
Intervention: 5.4 mg yohimbine plus 10 mg isoxsuprine 3 times daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: 400 mg pentoxifylline 3 times daily
Number of subjects: 20
Study: 1416272

Group type: EXPERIMENTAL
Intervention: Group EF: 5 micrograms.kg‐1 of fentanyl followed by 0.3 mg.kg‐1 of etomidate.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Group F: 30 micrograms.kg‐1 of fentanyl.
Number of subjects: 24
Study: 4000854

Group type: EXPERIMENTAL
Intervention: Upper limb movements (experimental groups)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Lower limb movements (experimental groups)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Direct practice on the criterion task (Exp. 2)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Constant practice on a modification of the criterion task (Exp. 2)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Variable practice on several different modifications of the criterion task (Exp. 2)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Amount of practice (general conclusion)
Number of subjects: 88
Study: 31704108

Group type: EXPERIMENTAL
Intervention: Fresh Empire campaign treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control markets
Number of subjects: 30
Study: 30681410

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 480

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study: 28759333

Group type: EXPERIMENTAL
Intervention: Pattern: ABCDE with photorealistic images
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Pattern: UDS with photorealistic images
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Illustrations
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Photorealistic images with high self-efficacy
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Photorealistic images with mean or lower self-efficacy
Number of subjects: 92
Study: 25962788

Group type: EXPERIMENTAL
Intervention: Integrated motivational interviewing and cognitive behavioural therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Therapist-rated alliance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Client-rated alliance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Client insecure attachment avoidance
Number of subjects: 0
Study: 23463680

Group type: EXPERIMENTAL
Intervention: Low muscle temperature (TmL)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fatigue
Number of subjects: 15
Study: 21569510

Group type: EXPERIMENTAL
Intervention: 12-session standardised curriculum based on the comprehensive social influence model
Number of subjects: 7079

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 7079
Study: 18070931

Group type: EXPERIMENTAL
Intervention: Ciclesonide 40 microg
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: Ciclesonide 160 microg
Number of subjects: 661

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 661
Study: 17066118

Group type: COMPARATOR
Intervention: Medial branch blocks using bupivacaine (Control Group I)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cervical medial branch blocks with bupivacaine and Sarapin (Group II)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cervical medial branch blocks with bupivacaine and betamethasone (Group III)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cervical medial branch blocks with bupivacaine, Sarapin, and betamethasone (Group IV)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Non-steroid group (combined Group I and II)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Steroid group (combined Group III and IV)
Number of subjects: 60
Study: 14984643

Group type: EXPERIMENTAL
Intervention: Theory-based self-efficacy coaching
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-efficacy intervention
Number of subjects: 0
Study: 11765597

Group type: EXPERIMENTAL
Intervention: Bacterial immunostimulant (Symbioflor 1, cells and autolysate of human Enterococcus faecalis)
Number of subjects: 136
Study: 9293232

Group type: EXPERIMENTAL
Intervention: Self-regulation procedures
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Self-regulation procedures plus explicit attributional retraining
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normally achieving students (additional control group)
Number of subjects: 60
Study: 8446670

Group type: EXPERIMENTAL
Intervention: Ondansetron 0.15, 0.3, or 0.45 mg/kg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Ondansetron 0.01, 0.02, or 0.04 mg/kg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Ondansetron (various doses)
Number of subjects: 14
Study: 2949169

Group type: EXPERIMENTAL
Intervention: Doxazosin (1 mg daily, titrated to double every two weeks)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Doxazosin (8 weeks treatment)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (two week phase)
Number of subjects: 8
Study: 29764246

Group type: EXPERIMENTAL
Intervention: Intralesional sodium stibogluconate (SSG)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Intralesional metronidazole
Number of subjects: 188
Study: 29468770

Group type: EXPERIMENTAL
Intervention: Cervical pessary
Number of subjects: 133

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 133
Study: 26910854

Group type: EXPERIMENTAL
Intervention: Terrain (experimental attention training game)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Tetris (control game)
Number of subjects: 31
Study: 24518180

Group type: EXPERIMENTAL
Intervention: IDeg 200 U/mL
Number of subjects: 373

Group type: COMPARATOR
Intervention: IDeg 100 U/mL
Number of subjects: 373
Study: 22983778

Group type: EXPERIMENTAL
Intervention: Titrated intravenous norepinephrine (NE) infusion
Number of subjects: 4
Study: 20075533

Group type: EXPERIMENTAL
Intervention: Autologous blood removal (10% of estimated blood volume for Hb > 12g%, 7% for Hb < 12g%)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control group (no autologous blood removal)
Number of subjects: 188
Study: 18042473

Group type: EXPERIMENTAL
Intervention: Formoterol fumarate inhalation solution 20 microg BID via nebulizer (FFIS)
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Formoterol fumarate 12 microg BID via dry powder inhaler (FA)
Number of subjects: 351

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351